Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BDB001 |
Synonyms | |
Therapy Description |
BDB001 is a Toll-like receptor agonist that may enhance the immune response (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BDB001 | BDB-001|BDB 001 | BDB001 is a Toll-like receptor agonist that may enhance the immune response (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04819373 | Phase II | BDB001 | BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors | Completed | USA | 0 |
NCT03486301 | Phase I | BDB001 BDB001 + Pembrolizumab | Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab | Active, not recruiting | USA | 0 |